| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.39 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |